NP49425 Generic and Biosimilar Transition Medicines
Sector: Pharmaceutical products • Location: United Kingdom
Source: Find a Tender Service (UK)
The estimated values referred to in Section II.I.7 and Section V.2.4 (and within all Lots) cover both the initial duration (which is variable, depending on the Lot) and the optional extension period (which is variable, depending on the Lot) -- covering a maximum total duration of forty-eight (48) months. Details of individual product lines awarded within a specific Lot can be requested from the na
- Status
- Unknown
- Sector
- Pharmaceutical products
- Location
- United Kingdom
- Updated
- 3 Nov 2026
- Source
- Find a Tender Service (UK)
ConstructChat
Ask ConstructChat about NP49425 Generic and Biosimilar Transition Medicines
Pick a question to edit it, or write your own.
First answer free · no account
Tender Information FAQ
Tender Information
Participants
| Not available for this record. |
Status
Original status | unknown |
Taiyo status | Unknown |
Taiyo last update | 2026-11-03 |
Contact
| Not available for this record. |
Description
Description | The estimated values referred to in Section II.I.7 and Section V.2.4 (and within all Lots) cover both the initial duration (which is variable, depending on the Lot) and the optional extension period (which is variable, depending on the Lot) -- covering a maximum total duration of forty-eight (48) months. Details of individual product lines awarded within a specific Lot can be requested from the named person at the head of this notice. (SC Ref:827046) |
Original sector | Pharmaceutical products |
Location
Country | United Kingdom (UK) |
Source
Source | Find a Tender Service (UK) |
URL |
More Details
Record type | Tender |
Article published date | 2026-09-21 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this tender
- News and media coverage
- Technical research
Free account · no card · lands you back on this tender